Premium
Eye drop psychosis in Parkinson's disease: a cautionary tale
Author(s) -
Ferris Amy,
Mohamed Biju,
Thomas Chris
Publication year - 2018
Publication title -
progress in neurology and psychiatry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.19
H-Index - 12
eISSN - 1931-227X
pISSN - 1367-7543
DOI - 10.1002/pnp.515
Subject(s) - drooling , anticholinergic , medicine , delirium , hypersalivation , psychosis , bradycardia , atropine , anesthesia , psychology , psychiatry , surgery , heart rate , blood pressure
Anticholinergic agents are used in a number of conditions ranging from overactive bladder and bradycardia to travel sickness but side‐effects such as hallucinations, impaired memory and restlessness are increasingly recognised, though still under‐reported in clinical practice. In Parkinson's disease anticholinergics such as atropine are recommended by NICE for the management of excessive drooling. Dr Ferris et al. present such a case where commencing sublingual atropine drops caused a patient to develop hyperactive delirium and psychosis. They also discuss the subsequent clinical management steps.